Corticosteroid
Abiraterone + Prednisone for Prostate Cancer
Recruiting1 awardPhase 2
Homewood, Alabama
This trial will investigate whether adding abiraterone acetate + prednisone to the current standard of care (GnRH) can prolong the time until cancer growth is evident, as well as collecting safety information about this combination therapy.
Antiandrogen
Apalutamide + Abiraterone for Prostate Cancer
Recruiting1 awardPhase 2
New Orleans, Louisiana
This trial is a non-comparative pilot study of apalutamide and abiraterone acetate in African American and Caucasian men with mCRPC. The study's primary goal is to prospectively estimate the median PFS of the two groups of men. Secondary objectives include: PSA kinetics, radiographic assessments, safety and tolerability, and incidence of hypertension in the two populations.
Corticosteroid
Abiraterone + Prednisone/Olaparib for Prostate Cancer
Recruiting3 awardsPhase 2
Duarte, California
This trial is testing a new cancer treatment for men with metastatic castration resistant prostate cancer. It is a 1:1:1 randomized open-label multicenter phase II study, which means that patients will be randomly assigned to one of three different treatment groups. The study will take place at multiple centers, and patients will be observed over the course of the trial.
Popular Filters
Phase 3 Trials
Corticosteroid
Apalutamide + Abiraterone Acetate + Prednisone for Prostate Cancer
Recruiting1 awardPhase 3
Phoenix, Arizona
This trial tests apalutamide added to a standard treatment for advanced prostate cancer. It targets patients whose cancer has spread and who haven't had chemotherapy. The treatment works by blocking and lowering male hormones that help cancer grow. Apalutamide has shown efficacy in treating different stages of prostate cancer.
Herbal Supplement
Abiraterone for Prostate Cancer
Recruiting1 awardPhase 2 & 3
North Bethesda, Maryland
This trial uses a combination of three drugs to treat prostate cancer. It targets men with prostate cancer to see how their genes affect treatment results. The drugs work by lowering hormones, reducing inflammation, and controlling hormone levels.
PARP Inhibitor
Niraparib + Abiraterone Acetate + Prednisone for Metastatic Prostate Cancer
Recruiting1 awardPhase 3
Homewood, Alabama
This trial will compare the effect of adding niraparib to abiraterone acetate plus prednisone, versus abiraterone acetate plus prednisone and placebo, in men with metastatic castration-resistant prostate cancer.
PARP Inhibitor
Olaparib + Abiraterone for Prostate Cancer
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing the combination of olaparib and abiraterone versus placebo and abiraterone to see if it is more effective and has fewer side effects in patients with mCRPC who have not received prior chemotherapy or NHAs.
Trials With No Placebo
Corticosteroid
Abiraterone + Niclosamide + Prednisone for Prostate Cancer
Recruiting1 awardPhase 2
Sacramento, California
This trial is testing a combination of drugs to treat hormone-resistant prostate cancer. The drugs may work by lowering the amount of androgen in the body or by blocking a signal that can cause prostate cancer cell growth.
Steroidogenesis Inhibitor
Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Recruiting1 awardPhase < 1
Tampa, Florida
This trial will test whether an on and off schedule of taking abiraterone can prolong a cancer's response to the drug and help patients maintain their quality of life.
Steroid
Abiraterone + Prednisone for Prostate Cancer
Recruiting3 awards7 criteria
Boston, Massachusetts
"This trial is testing a new method to detect circulating tumor cells in the blood of prostate cancer patients without needing a biopsy. The study will analyze protein levels in these cells to see if they can predict how
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.